HHS Just Sent $247.9 Million Toward Addiction Care. Watch Where the Smaller Numbers Land.
The headline figure is real money. The line items inside it are the actual policy.
On September 25, HHS Secretary Robert F. Kennedy Jr. announced $247.9 million in new grants for addiction treatment, overdose prevention, and mental health services, framing it as part of the administration’s “Great American Recovery” push. “HHS is investing nearly $250 million to put lifesaving treatment and recovery services directly into communities across America,” Kennedy said.
A quarter-billion dollars sounds like a plan. The three line items inside it are the actual plan, and they’re worth more scrutiny than the round number on top of them.
Break the total apart and the shape gets specific fast. SAMHSA’s own release puts $69.4 million toward the Medication-Assisted Treatment – Prescription Drug and Opioid Addiction program — money aimed specifically at expanding access to buprenorphine, methadone, and naltrexone, the three medications with the strongest evidence for keeping people with opioid use disorder alive. Another $34.6 million goes to First Responders–CARA, which trains police officers, EMTs, and community members to carry and administer naloxone. A comparatively small $3.3 million goes to Comprehensive Opioid Recovery Centers — the programs meant to be a one-stop landing spot combining medication, counseling, and recovery support under one roof.
That last number is the one worth sitting with. Recovery centers are the piece of the system that actually holds someone once the overdose has been reversed and the prescription has been written — and it’s the smallest of the three named allocations, in a release that leads with a round number nearly seventy times its size.
The announcement arrives alongside genuinely good news: CDC’s latest provisional estimate puts overdose deaths at 66,937 for the twelve months ending in April 2026, down about 12% from the 76,176 estimated for the prior period. That decline is real, and it’s the kind of trend line that makes funding announcements land as momentum rather than triage. It’s also exactly the moment a smaller “recovery centers” line item deserves a harder question, not a softer one: is the money following where people are getting better, or following where the political message is easiest to make?
If you’re the person this grant is actually supposed to reach — waiting on a MAT slot, waiting on a bed at a recovery center that’s chronically underfunded relative to its waitlist — the number that matters to you was never $247.9 million. It’s whichever of these three programs has a program near you, and whether $3.3 million split across a country this size is enough to open a door instead of just naming one.
Sources Cited
- 01.A
- 02.A
- 03.B
Filed Under
policytreatmentSAMHSAFundingNaloxone
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Purdue Pharma No Longer Exists. Proving It Wrecked Your Life Just Got Harder Anyway.
Purdue Pharma dissolved this year under a $7.4 billion settlement. Arizona just banked $108 million from it. The individual victims the fund was built for are being denied at scale.
Policy & FundingSAMHSA Sent $247.9 Million to Treatment Programs This Week. Watch the Money Washington Isn't Protecting.
SAMHSA awarded $247.9 million for addiction treatment, first responder naloxone training and peer support this week. Here's what the money actually buys — and why the bigger fight over block grants matters more.
Policy & FundingThe DEA Is Rescheduling Marijuana Through a Process Its Own Watchdog Says Doesn't Exist on Paper
A GAO report published Sept 23 found the DEA has no documented procedures for how it schedules or reschedules controlled substances — landing in the middle of the marijuana Schedule I to III review that's already left states like California guessing.